- Fee assured
- Awaiting verification
- Accredited endoscopist
- Accredited endoscopist
Dr Keld graduated from the University of Manchester in 1999. He entering the North Western Deanery Gastroenterology training program 2003 - 2011.
During this period he has worked at seven North West and Manchester University Hospitals, having acquired comprehensive experience dealing with all aspects of General Internal Medicine, Gastroenterology and Hepatology. He was awarded a postgraduate degree in the Department of Medicine and Faculty of Life Sciences at the University of Manchester for his work investigating the molecular biology and genetics of Oesophageal and Gastric Cancer 2007 - 2009. This research has led to 12 publications in medical journals and presentations at regional, national and international conferences. He is currently the clinical lead for both Gastroenterology and Upper Gastrointestinal Cancer at Wrightinton, Wigan and Leigh NHS Foundation Trust and he is also an active board member of Manchester Cancer. In addition, he has published work on Coeliac Disease, Inflammatory Bowel Disease, Gastroparesis, Endoscopic Ultrasound, Diabetes, Barrett’s Oesophagus and Gastro-intestinal cancer pathways. This has enhanced his clinical competence and expertise in the speciality. Dr Keld continues to be involved in clinical research in his current role and he is a peer reviewer for international medical journals. Dr Keld is skilled in dealing in all aspects of Gastroenterology, He teaches at a national level for the Royal College of Surgeons and General Practioners, physician membership examinations and Colonoscopy training. Dr Keld is heavily involved in clinical audit and strives to improve patient services and experience.
Areas of interest
Irritable bowel syndrome (IBS); Reflux; Dyspepsia; Gallstones; Colonoscopy; sigmoidoscopy; gastroscopy; endoscopic ultrasound; Endoscopy - therapeutic; Biliary disease; Cancer diagnosis; ERCP (Endoscopic retrograde cholangiopancreatography); Pancreatic surgery / disorders; Bowel disease including inflammatory (IBD); Endoscopic procedures
- Clare Holding
- Euxton Hall Hospital Wigan Road Euxton Chorley PR7 6DY
- 01257 276261
- Lyndsey Daniels
- BMI The Beaumont Hospital Old Hall Clough Chorley New Road BOLTON BL6 4LA
- 01204 404446
- Sue Foster
- Christopher Home Royal Albert Edward Infirmary Wigan Lane WIGAN WN1 2NN
Current NHS consultant posts held
WWL NHS Foundation trust
Royal Albert Edward Infirmary, Wigan
Inflammatory bowel disease
Married with 3 children, cycling, football and golf.
R and D grant from WWLFT, supported by Welcome Trust Laboratory 2007
5,10-MTHFR C677T and risk of oesophago-gastric adenocarcinoma: funded by WWL and Molecular Medicine Ireland.
North West Clinical Research Prize, 2009.
WCG 2009. Travel Grant
UEGW 2010 Travel Grant
Manchester Medical Society Clinical Research Prize, 2011
Articles in peer review publications
The pitfalls of bedside glucometers.
R Keld, Y Ang Journal of the Royal Society of Medicine 2008 101:484.
The ERK-PEA3-MMP-1 axis is operative in oesophageal adenocarcinoma. R Keld, B Guo, P Downey, C Gulmann, Y Ang, A Sharrocks.
Molecular Cancer 2010, 9:313
Targeting signalling pathways in oesophageal adenocarcinoma is there a role for personalised medicine? R Keld, Y Ang World Journal of Gastroenterology 2011 Jun 21 17(23): 2781-90
Amyloidosis, an EUS view. R Keld, E Shuttleworth, E Benbow, R Willert Gastro-intestinal Endoscopy 2011 April 4 .
Pathogenesis, investigation and dietary and medical management of gastroparesis. R Keld, L Kinsey, V Athawal, S Lal. Journal of Human Nutrition and Dietetics 2011 July 21
ERK MAPK and PEA3 are adverse markers in gastric adenocarcinoma. R Keld, B Guo, P Downey, C Gulmann, Y Ang, A Sharrocks. British Journal of Cancer, 2011 Jun 28; 105(1) 124-30
Does weight adjusted Tumour Necrosis Factor alpha favour obese patients in Crohn’s disease? M Bhalme, A Sharma, R Keld, R Willert, S Campbell
European Journal of Gastroenterology and Hepatology 2013 May; 25(5) 543-9
Polymorphisms of 5,10-methylenetetrahydrofolate reductase C667T and risk of oesophago-gastric adenocarcinoma: a case control study. R Keld, M Thian, J Sajid, N Chiahau, N Kumar, Y Ang.
World Journal of Gastroenterology 2015
Diet and Nutrition for Gastrointestinal Disease
Chapter 3.6 Gastroparesis. R Keld and S Lal In press 2014
Effect of diagnosis, surveillance, and treatment of Barrett’s Oesophagus on health related quality of life. J Britton, R Keld, N Prasad, S Hamdy, J McLaughlin, Y Ang.
Lancet Gastroenterol Hepatol 2018.
Further 11 abracts presented in Scientific meetings and published in peer review papers
Courses offered to GPs
WWL Education centre
Royal College of General Practioners (Liverpool)
Management of dyspepsia and GORD
Caecal intubation rate for colonoscopy 93%
ERCP cannulation rate 92%
- MB ChB Manchester University 1999
- MRCP(UK) Royal College of Physicians (London) 2003
- MD Manchester University 2009
Reference number 4646697
Details of entry to specialist register
- CCT, 2011
Affiliations / memberships
General Medical Council
British Medical Association
British Society of Gastroenterology
- BMI The Beaumont Hospital, BL6 4LA
- 18:00 - 20:00
- 01204 404446
- Christopher HomeRoyal Albert Edward InfirmaryWigan
- 08:00 - 09:00
- 01942 244000
- Euxton Hall Hospital
- 09:00 - 11:30
- 01257 276261
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details